08/27/2025
3:13 PM | Agios Pharmaceuticals (Subject)
Scadden David (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/08/2025
5:53 PM | Agios Pharmaceuticals (Subject)
Goff Brian (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/04/2025
12:53 PM | Agios Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/31/2025
9:29 AM | Agios Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/31/2025
5:38 AM | Agios Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/17/2025
6:44 PM | Agios Pharmaceuticals (Subject)
BlackRock, Inc. (Filed by)
| Form SCHEDULE 13G/A | |
07/11/2025
3:59 PM | Agios Pharmaceuticals (Issuer)
Gheuens Sarah (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/10/2025
4:14 PM | Agios Pharmaceuticals (Subject)
Scadden David (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/10/2025
3:14 PM | Agios Pharmaceuticals (Issuer)
Backstrom Jay T. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/09/2025
3:59 PM | Agios Pharmaceuticals (Subject)
Gheuens Sarah (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/08/2025
6:01 AM | Agios Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for AGIO and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Agios Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. |
07/07/2025
6:32 PM | Agios Pharmaceuticals (Subject)
Bellevue Group AG (Filed by)
| Form SCHEDULE 13G | |
06/26/2025
4:22 PM | Agios Pharmaceuticals (Issuer)
Goff Brian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2025
4:23 PM | Agios Pharmaceuticals (Issuer)
Milanova Tsveta (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2025
4:24 PM | Agios Pharmaceuticals (Issuer)
Jones Cecilia (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2025
4:25 PM | Agios Pharmaceuticals (Issuer)
Gheuens Sarah (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2025
4:26 PM | Agios Pharmaceuticals (Issuer)
Burns James William (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/24/2025
3:01 PM | Agios Pharmaceuticals (Subject)
Burns James William (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/24/2025
3:05 PM | Agios Pharmaceuticals (Subject)
Gheuens Sarah (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/23/2025
3:17 PM | Agios Pharmaceuticals (Issuer)
Smith Cynthia (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2025
3:18 PM | Agios Pharmaceuticals (Issuer)
Scadden David (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2025
3:20 PM | Agios Pharmaceuticals (Issuer)
Owen Adams Catherine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2025
3:21 PM | Agios Pharmaceuticals (Issuer)
Ho Maykin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2025
3:23 PM | Agios Pharmaceuticals (Issuer)
FOUSE JACQUALYN A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2025
3:24 PM | Agios Pharmaceuticals (Issuer)
Foster-Cheek Kaye I (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2025
3:25 PM | Agios Pharmaceuticals (Issuer)
CAPELLO JEFFREY D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2025
3:27 PM | Agios Pharmaceuticals (Issuer)
Ballal Rahul D. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2025
3:41 PM | Agios Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
06/18/2025
3:31 PM | Agios Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/13/2025
1:50 PM | Agios Pharmaceuticals (Subject)
BB BIOTECH AG (Filed by)
| Form SCHEDULE 13G/A | |
05/01/2025
9:26 AM | Agios Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/01/2025
5:32 AM | Agios Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/10/2025
3:02 PM | Agios Pharmaceuticals (Issuer)
FOUSE JACQUALYN A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/08/2025
4:58 PM | Agios Pharmaceuticals (Subject)
FOUSE JACQUALYN A (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/07/2025
3:15 PM | Agios Pharmaceuticals (Issuer)
Viswanadhan Krishnan (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
03/07/2025
3:18 PM | Agios Pharmaceuticals (Issuer)
Viswanadhan Krishnan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2025
4:27 PM | Agios Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/04/2025
3:12 PM | Agios Pharmaceuticals (Issuer)
Milanova Tsveta (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/03/2025
3:42 PM | Agios Pharmaceuticals (Subject)
Burns James William (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/03/2025
3:44 PM | Agios Pharmaceuticals (Subject)
Gheuens Sarah (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/03/2025
3:46 PM | Agios Pharmaceuticals (Subject)
Goff Brian (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Tax Drain Deadline: Protect Your Wealth Before September 15th (Ad) On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed professionals, retirees, and high-net-worth savers.
But the wealthy aren’t just writing checks. They’re moving fast to protect capital and purchasing power using legal, IRS-compliant strategies.
American Alternative Assets just released the Mar-A-Lago Accord, a free guide revealing how to reduce Q3 tax exposure and reposition wealth before it’s drained. Click here to download the guide and protect your assets before Sept 15th. |
03/03/2025
3:49 PM | Agios Pharmaceuticals (Subject)
Jones Cecilia (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/03/2025
3:50 PM | Agios Pharmaceuticals (Subject)
Milanova Tsveta (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/14/2025
1:35 PM | Agios Pharmaceuticals (Subject)
BB BIOTECH AG (Filed by)
| Form SCHEDULE 13G/A | |
02/13/2025
8:26 AM | Agios Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/13/2025
5:32 AM | Agios Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/13/2025
5:01 AM | Agios Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/04/2025
11:02 AM | Agios Pharmaceuticals (Subject)
Farallon Capital Partners, L.P. (Filed by)
| Form SCHEDULE 13G/A | |
01/13/2025
6:01 AM | Agios Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/07/2025
4:05 PM | Agios Pharmaceuticals (Issuer)
Milanova Tsveta (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
5:36 AM | Agios Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2024
3:14 PM | Agios Pharmaceuticals (Issuer)
Washburn Theodore James Jr. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/08/2024
3:17 PM | Agios Pharmaceuticals (Subject)
Ballal Rahul D. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/08/2024
1:40 PM | Agios Pharmaceuticals (Subject)
Farallon Capital Partners, L.P. (Filed by)
| Form SC 13G/A | |
10/31/2024
8:20 AM | Agios Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/31/2024
5:56 AM | Agios Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/30/2024
3:15 PM | Agios Pharmaceuticals (Issuer)
Jones Cecilia (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
MarketBeat All Access